Carbohydrate metabolism disorder is a severe systemic disease leading to the development of a full range of metabolic disorders, accompanied by obesity, vascular pathology, connective tissue damage. Therefore, a range of activities is very important for such patients, which allows you to reduce blood glucose levels. These procedures include dietary nutrition, moderate load, reduced stress, and, if necessary, gastric surgery is performed to reduce food drive, and, as a result, reduced body weight. Objective - investigate glucose, fructose, and galactose levels in saliva of patients with impaired carbohydrate metabolism and establish a relationship with blood plasma parameters. Saliva samples obtained from 38 patients: patients with DM-2, patients with DM-2 and obesity after bariatric surgery, patients with prediabetes, obesity, and impaired glucose tolerance. The control group made up of healthy volunteers who denied having somatic pathology. Within the framework of the study, a protocol was formed containing the values of anthropometric indices and assessments of body parameters, the results of the study of lipid and carbohydrate spectrum parameters in plasma. Saliva samples calculated for salivation rate, saliva pH, and glucose, fructose, and galactose in μg/ml determined by high-liquid chromatography. Showed that saliva of patients with diabetes mellitus type 2 showed significantly (p<0.05) low level of fructose, patients with glucose tolerance significantly (p<0.05) high galactose content, and patients with diabetes mellitus type 2 after bariatric surgery maximum (p<0.05) amount of glucose. In saliva, the content of monosaccharides is determined, but their amount is small and requires the use of highly sensitive methods. Differences in the quantitative and qualitative content of monosaccharides in saliva are determined by the type of carbohydrate metabolism disorder.
Download full-text PDF |
Source |
---|
Asian Pac J Cancer Prev
December 2024
Department of Physiology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.
Objective: Gastrointestinal cancer is one of the most common causes of death worldwide. As there are no clinical symptoms at the beginning of the disease, the diagnosis can be delayed and the stage increased. Timely diagnosis is therefore crucial.
View Article and Find Full Text PDFBiosens Bioelectron
December 2024
School of Materials Science and Chemical Engineering, Ningbo University, Ningbo, Zhejiang, 315200, China. Electronic address:
Routine screening for cardiovascular diseases (CVDs) through point-of-care assays for at-home or community-based testing of salivary biomarkers can significantly improve patient outcomes. However, its translatability has been hindered by a dearth of biosensing devices that streamline assay procedures for rapid biomarker quantitation. To address this challenge through end-to-end engineering, we developed an in-house, all-in-one microfluidic immunosensing device that integrates on-chip vibration-enhanced incubation, magnetic-assisted separation using immune magnetic bead probes, and colorimetric readout via absorbance measurements.
View Article and Find Full Text PDFSci China Life Sci
December 2024
State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.
Salivary proteins serve multifaceted roles in maintaining oral health and hold significant potential for diagnosing and monitoring diseases due to the non-invasive nature of saliva sampling. However, the clinical utility of current saliva biomarker studies is limited by the lack of reference intervals (RIs) to correctly interpret the testing result. Here, we developed a rapid and robust saliva proteome profiling workflow, obtaining coverage of >1,200 proteins from a 50-µL unstimulated salivary flow with 30 min gradients.
View Article and Find Full Text PDFSci Rep
December 2024
School of Dentistry, University of California Los Angeles, 10833 Le Conte Ave., 73-022 CHS, Los Angeles, CA, 90095-1668, USA.
We developed a 4-parameter clinical assay using Electric Field Induced Release and Measurement (EFIRM) technology to simultaneously assess SARS-CoV-2 RNA (vRNA), nucleocapsid antigen, host binding (BAb) and neutralizing antibody (NAb) levels from a drop of saliva with performance that equals or surpasses current EUA-approved tests. The vRNA and antigen assays achieved lower limit of detection (LOD) of 100 copies/reaction and 3.5 TCID₅₀/mL, respectively.
View Article and Find Full Text PDFSci Rep
December 2024
Center for Oral Health Research, College of Dentistry, University of Kentucky, Lexington, KY, USA.
Type 2 diabetes mellitus (T2DM) is associated with cellular abnormalities, tissue and organ dysfunctions, and periodontitis. This investigation examined the relationship between the oral microbiome and salivary biomarkers in T2DM patients with or without periodontitis. This cohort (35-80 years) included systemically healthy non-periodontitis (NP; n = 31), T2DM without periodontitis (DWoP; n = 32) and T2DM with periodontitis (DWP; n = 29).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!